FI965022A0 - Pyratsolo- ja pyrrolopyridiinejä - Google Patents

Pyratsolo- ja pyrrolopyridiinejä

Info

Publication number: FI965022A0
Authority: FI; Finland
Prior art keywords: pyrrolopyridines; pyrazolo; formulawherein; stress; compounds
Prior art date: 1994-06-16

Application number

FI965022A

Other languages

English (en)

Swedish (sv)

Other versions

FI965022L (fi

FI112659B (fi

Inventor

Yuhpyng L Chen

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-06-16

Filing date

1996-12-13

Publication date

1996-12-13

1996-12-13 Application filed by Pfizer filed Critical Pfizer

1996-12-13 Publication of FI965022L publication Critical patent/FI965022L/fi

1996-12-13 Publication of FI965022A0 publication Critical patent/FI965022A0/fi

2003-12-31 Application granted granted Critical

2003-12-31 Publication of FI112659B publication Critical patent/FI112659B/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Diabetes (AREA)
Pain & Pain Management (AREA)
Immunology (AREA)
Endocrinology (AREA)
Hematology (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Rheumatology (AREA)
Addiction (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Child & Adolescent Psychology (AREA)
Hospice & Palliative Care (AREA)
Anesthesiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Controls And Circuits For Display Device (AREA)
Projection Apparatus (AREA)

FI965022A 1994-06-16 1996-12-13 Pyratsolopyridiinejä FI112659B (fi)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US26005594A	1994-06-16	1994-06-16
US26005594		1994-06-16
IB9500373		1995-05-18
PCT/IB1995/000373 WO1995034563A1 (en)	1994-06-16	1995-05-18	Pyrazolo and pyrrolopyridines

Publications (3)

Publication Number	Publication Date
FI965022L FI965022L (fi)	1996-12-13
FI965022A0 true FI965022A0 (fi)	1996-12-13
FI112659B FI112659B (fi)	2003-12-31

Family

ID=22987613

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI965022A FI112659B (fi)	1994-06-16	1996-12-13	Pyratsolopyridiinejä

Country Status (27)

Country	Link
US (1)	US6248753B1 (fi)
EP (1)	EP0765327B1 (fi)
JP (1)	JP2891544B2 (fi)
KR (1)	KR100235277B1 (fi)
CN (1)	CN1056611C (fi)
AT (1)	ATE182332T1 (fi)
AU (1)	AU687196B2 (fi)
BR (1)	BR9502707A (fi)
CA (1)	CA2192820C (fi)
CO (1)	CO4290424A1 (fi)
CZ (1)	CZ287613B6 (fi)
DE (1)	DE69510940T2 (fi)
DK (1)	DK0765327T3 (fi)
ES (1)	ES2135062T3 (fi)
FI (1)	FI112659B (fi)
GR (1)	GR3031166T3 (fi)
HU (1)	HU219911B (fi)
IL (1)	IL114003A (fi)
MX (1)	MX9606504A (fi)
NO (1)	NO307968B1 (fi)
NZ (1)	NZ284846A (fi)
PE (1)	PE13396A1 (fi)
PL (1)	PL181895B1 (fi)
RU (1)	RU2135498C1 (fi)
TW (1)	TW432064B (fi)
WO (1)	WO1995034563A1 (fi)
ZA (1)	ZA954679B (fi)

Families Citing this family (88)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6403599B1 (en)	1995-11-08	2002-06-11	Pfizer Inc	Corticotropin releasing factor antagonists
US7125880B1 (en)	1995-06-06	2006-10-24	Pfizer Inc.	Corticotropin releasing factor antagonists
AU738304B2 (en) *	1995-10-13	2001-09-13	Neurogen Corporation	Certain pyrrolopyridine derivatives; novel CRF 1 specific ligands
US6992188B1 (en)	1995-12-08	2006-01-31	Pfizer, Inc.	Substituted heterocyclic derivatives
CA2249598A1 (en) *	1996-03-26	1997-10-02	Paul Joseph Gilligan	Aryloxy- and arylthio-fused pyridines and pyrimidines and derivatives
ZA971896B (en)	1996-03-26	1998-09-07	Du Pont Merck Pharma	Aryloxy-and arythio-fused pyridines and pyrimidines and derivatives
US6107300A (en) *	1996-03-27	2000-08-22	Dupont Pharmaceuticals	Arylamino fused pyrimidines
ZA972497B (en)	1996-03-27	1998-09-25	Du Pont Merck Pharma	Arylamino fused pyridines and pyrimidines
ZA973884B (en)	1996-05-23	1998-11-06	Du Pont Merck Pharma	Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
US6060478A (en) *	1996-07-24	2000-05-09	Dupont Pharmaceuticals	Azolo triazines and pyrimidines
US6313124B1 (en)	1997-07-23	2001-11-06	Dupont Pharmaceuticals Company	Tetrazine bicyclic compounds
US7094782B1 (en)	1996-07-24	2006-08-22	Bristol-Myers Squibb Company	Azolo triazines and pyrimidines
US6191131B1 (en)	1997-07-23	2001-02-20	Dupont Pharmaceuticals Company	Azolo triazines and pyrimidines
US6124289A (en) *	1996-07-24	2000-09-26	Dupont Pharmaceuticals Co.	Azolo triazines and pyrimidines
CZ292806B6 (cs) *	1996-08-06	2003-12-17	Pfizer Inc.	Pyrido- nebo pyrimido-6,6- nebo -6,7-bicyklické deriváty, farmaceutické kompozice na jejich bázi
TW477787B (en) *	1996-08-27	2002-03-01	Pfizer	Pyrido six-membered nitrogen-containing cyclic ring derivatives having corticotropin releasing factor antagonist activity and pharmaceutical composition containing same
JP2001502300A (ja)	1996-09-16	2001-02-20	デュポンファーマシューティカルズカンパニー	ピラジノン類およびトリアジノン類およびその誘導体類
JP2001511813A (ja) *	1997-02-18	2001-08-14	ニューロクラインバイオサイエンシーズ，インコーポレイテッド	Ｃｒｆレセプターアンタゴニストおよびそれらに関連する方法
AU746706B2 (en) *	1997-07-03	2002-05-02	Du Pont Pharmaceuticals Company	Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
DE69807085D1 (de)	1997-09-02	2002-09-12	Bristol Myers Squibb Pharma Co	Heterocyclyl-substituierte annellierte pyridine und pyrimidine als antagonisten des corticotropin freisetzenden hormons (crh), verwendbar für die behandlung von cns und stress
NL1010018C2 (nl) *	1997-09-09	1999-03-10	Duphar Int Res	Chinoline en chinazoline derivaten met corticotropine releasing factor (CRF) antagonistische werking.
US6187777B1 (en)	1998-02-06	2001-02-13	Amgen Inc.	Compounds and methods which modulate feeding behavior and related diseases
US6472402B1 (en)	1998-04-02	2002-10-29	Neurogen Corporation	Aminoalkyl substituted 5,6,7,8-Tetrahydro-9H-Pyridino [2,3-B]indole derivatives
AU3378799A (en)	1998-04-02	1999-10-25	Neurogen Corporation	Aminoalkyl substituted pyrrolo(2,3-b)pyridine and pyrrolo(2,3-d)pyrimidine derivatives: modulators of crf1 receptors
CA2326319A1 (en)	1998-04-02	1999-10-14	Neurogen Corporation	Aminoalkyl substituted 5,6,7,8-tetrahydro-9h pyrimidino[2,3-b]indole and 5,6,7,8-tetrahydro-9h-pyrimidino[4,5-b]indole derivatives: crf1 specific ligands
US6365589B1 (en)	1998-07-02	2002-04-02	Bristol-Myers Squibb Pharma Company	Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists
DE19837387A1 (de) *	1998-08-18	2000-02-24	Aventis Res & Tech Gmbh & Co	3'-Desoxypentopyranosyl-Nucleinsäure, ihre Herstellung und Verwendung
US6174912B1 (en)	1998-08-21	2001-01-16	Dupont Pharmaceuticals Company	Nitrogen substituted imidazo[4,5-C]pyrazoles as corticotropin releasing hormone antagonists
ES2180338T3 (es)	1998-11-12	2003-02-01	Neurocrine Biosciences Inc	Antagonistas del receptor de crf y metodos relacionados.
JP2002529469A (ja)	1998-11-12	2002-09-10	ニューロクラインバイオサイエンシーズ，インコーポレイテッド	Ｃｒｆレセプターアンタゴニストおよびそれに関する方法
US6531475B1 (en)	1998-11-12	2003-03-11	Neurocrine Biosciences, Inc.	CRF receptor antagonists and methods relating thereto
US6271380B1 (en)	1998-12-30	2001-08-07	Dupont Pharmaceuticals Company	1H-imidazo[4,5-d]pyridazin-7-ones, 3H-imidazo-[4,5-c]pyridin-4-ones and corresponding thiones as corticotropin releasing factor (CRF) receptor ligands
EP1040831A3 (en)	1999-04-02	2003-05-02	Pfizer Products Inc.	Use of corticotropin releasing factor (CRF) antagonists to prevent sudden death
US6387894B1 (en)	1999-06-11	2002-05-14	Pfizer Inc.	Use of CRF antagonists and renin-angiotensin system inhibitors
US6432989B1 (en) *	1999-08-27	2002-08-13	Pfizer Inc	Use of CRF antagonists to treat circadian rhythm disorders
CZ20021086A3 (cs)	1999-09-30	2002-10-16	Neurogen Corporation	Alkylendiaminem substituované heterocykly
IL139197A0 (en)	1999-10-29	2001-11-25	Pfizer Prod Inc	Use of corticotropin releasing factor antagonists and related compositions
TWI271406B (en)	1999-12-13	2007-01-21	Eisai Co Ltd	Tricyclic condensed heterocyclic compounds, preparation method of the same and pharmaceuticals comprising the same
EP1244666A1 (en) *	1999-12-17	2002-10-02	Bristol-Myers Squibb Pharma Company	Imidazopyrimidinyl and imidazopyridinyl derivatives
AU2001232271A1 (en) *	2000-02-14	2001-08-20	Japan Tobacco Inc.	Preventives/remedies for postoperative stress
AU2001253540A1 (en)	2000-04-25	2001-11-07	Bristol-Myers Squibb Company	Use of 5-thio-, sulfinyl- and sulfonylpyrazolo(3,4-b)-pyridines as cyclin dependent kinase inhibitors
US6630476B2 (en) *	2000-07-07	2003-10-07	Bristol-Myers Squibb Pharma Company	Pyrrolo [3,4-d] pyrimidines as corticotropin releasing factor (CRF) antagonists
PE20020394A1 (es)	2000-08-18	2002-06-21	Agouron Pharma	Compuestos de pirazol y composiciones farmaceuticas que los contienen, que modulan y/o inhiben la actividad de erab/hadh2
DE10042093A1 (de) *	2000-08-26	2002-03-07	Dresden Arzneimittel	Antikonvulsiv wirkende 6,7-Dihydro-pyrrolo[3,4-d]pyridin-5-one und Verfahren zu deren Darstellung
WO2002024703A1 (en)	2000-09-22	2002-03-28	Akzo Nobel N.V.	Bicyclic heteroaromatic compounds
TWI312347B (en)	2001-02-08	2009-07-21	Eisai R&D Man Co Ltd	Bicyclic nitrogen-containing condensed ring compounds
DE10110747A1 (de)	2001-03-07	2002-09-12	Bayer Ag	Substituierte 2,6-Diamino-3,5-dicyano-4-aryl-pyridine und ihre Verwendung
JP4206273B2 (ja)	2001-04-27	2009-01-07	エーザイ・アール・アンド・ディー・マネジメント株式会社	ピラゾロ［１，５−ａ］ピリジン化合物およびその医薬
GB0117396D0 (en)	2001-07-17	2001-09-05	Glaxo Group Ltd	Chemical compounds
GB0128287D0 (en) *	2001-11-26	2002-01-16	Smithkline Beecham Plc	Novel method and compounds
CN1326855C (zh) *	2001-12-04	2007-07-18	弗·哈夫曼-拉罗切有限公司	稠环吡唑衍生物
US7291630B2 (en) *	2002-03-28	2007-11-06	Eisai Co., Ltd.	Azaindoles as inhibitors of c-Jun N-terminal kinases
GB0230045D0 (en) *	2002-12-23	2003-01-29	Glaxo Group Ltd	Compounds
US7176216B2 (en)	2002-10-22	2007-02-13	Eisai Co., Ltd.	7-phenylpyrazolopyridine compounds
KR100984085B1 (ko)	2002-10-22	2010-09-30	에자이 알앤드디 매니지먼트 가부시키가이샤	7-페닐 피라졸로피리딘 화합물
TWI270549B (en)	2002-12-26	2007-01-11	Taisho Pharmaceutical Co Ltd	Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group
GB0308208D0 (en)	2003-04-09	2003-05-14	Glaxo Group Ltd	Chemical compounds
MY144903A (en)	2004-06-17	2011-11-30	Novartis Ag	Pyrrolopyridine derivatives and their use as crth2 antagonists
DE102004042607A1 (de)	2004-09-03	2006-03-09	Bayer Healthcare Ag	Substituierte Phenylaminothiazole und ihre Verwendung
DE602005014375D1 (de) *	2004-10-19	2009-06-18	Neurocrine Biosciences Inc	Crf-rezeptor-antagonisten und zugehörige verfahren
WO2007031838A1 (en)	2005-09-16	2007-03-22	Ranbaxy Laboratories Limited	Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
GB0525143D0 (en) *	2005-12-09	2006-01-18	Novartis Ag	Organic compounds
GB0525337D0 (en) *	2005-12-13	2006-01-18	Novartis Ag	Organic compounds
MX2008011220A (es) *	2006-03-07	2008-09-11	Array Biopharma Inc	Compuestos de pirazol heterobiciclicos y metodos de uso.
CN101460497A (zh) *	2006-04-04	2009-06-17	菲布罗根有限公司	作为hif调节剂的吡咯并吡啶和噻唑并吡啶化合物
TW200815349A (en)	2006-06-22	2008-04-01	Astrazeneca Ab	New compounds
DE102006042143A1 (de)	2006-09-08	2008-03-27	Bayer Healthcare Aktiengesellschaft	Neue substituierte Bipyridin-Derivate und ihre Verwendung
DE102006056740A1 (de)	2006-12-01	2008-06-05	Bayer Healthcare Ag	Cyclisch substituierte 3,5-Dicyano-2-thiopyridine und ihre Verwendung
DE102006056739A1 (de)	2006-12-01	2008-06-05	Bayer Healthcare Ag	Substituierte 4-Amino-3,5-dicyano-2-thiopyridine und ihre Verwendung
DE102007035367A1 (de)	2007-07-27	2009-01-29	Bayer Healthcare Ag	Substituierte Aryloxazole und ihre Verwendung
DE102007036076A1 (de)	2007-08-01	2009-02-05	Bayer Healthcare Aktiengesellschaft	Dipeptoid-Produgs und ihre Verwendung
DE102007061763A1 (de)	2007-12-20	2009-06-25	Bayer Healthcare Ag	Substituierte azabicyclische Verbindungen und ihre Verwendung
DE102007061764A1 (de)	2007-12-20	2009-06-25	Bayer Healthcare Ag	Anellierte Cyanopyridine und ihre Verwendung
DE102008013587A1 (de)	2008-03-11	2009-09-17	Bayer Schering Pharma Aktiengesellschaft	Heteroaryl-substituierte Dicyanopyridine und ihre Verwendung
KR101601994B1 (ko)	2008-04-15	2016-03-17	에자이 알앤드디 매니지먼트 가부시키가이샤	3-페닐피라졸로[5,1-ｂ]티아졸 화합물
US8791146B2 (en)	2008-05-29	2014-07-29	Bayer Intellectual Property Gmbh	2-alkoxy-substituted dicyanopyridines and their use
TW201020244A (en)	2008-11-14	2010-06-01	Astrazeneca Ab	New compounds
DE102008062567A1 (de)	2008-12-16	2010-06-17	Bayer Schering Pharma Aktiengesellschaft	Dipeptoid-Prodrugs und ihre Verwendung
DE102009006602A1 (de)	2009-01-29	2010-08-05	Bayer Schering Pharma Aktiengesellschaft	Alkylamino-substituierte Dicyanopyridine und deren Aminosäureester-Prodrugs
AR078521A1 (es)	2009-10-08	2011-11-16	Eisai R&D Man Co Ltd	Compuesto pirazolotiazol
DE102010030688A1 (de)	2010-06-30	2012-01-05	Bayer Schering Pharma Aktiengesellschaft	Substituierte Dicyanopyridine und ihre Verwendung
US20120058983A1 (en)	2010-09-02	2012-03-08	Bayer Pharma Aktiengesellschaft	Adenosine A1 agonists for the treatment of glaucoma and ocular hypertension
CA2836463A1 (en)	2011-05-17	2012-11-22	Discoverybiomed Inc.	Treating protein folding disorders with small molecule cftr correctors
WO2014078568A1 (en)	2012-11-14	2014-05-22	The Johns Hopkins University	Methods and compositions for treating schizophrenia
US9546176B2 (en)	2012-11-20	2017-01-17	Discoverybiomed, Inc.	Small molecule bicyclic and tricyclic CFTR correctors
AU2013348018A1 (en)	2012-11-20	2015-06-04	Discoverybiomed, Inc.	Small molecule CFTR correctors
TWI498325B (zh)	2013-01-18	2015-09-01	Hoffmann La Roche	３－取代吡唑及其用途
CN108558876B (zh) *	2018-05-28	2020-08-04	中南大学	吡唑[3,4-b]并吡啶类衍生物及其制备方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3925388A (en) *	1971-08-05	1975-12-09	Squibb & Sons Inc	4-Piperazino-{8 3,4-b{9 pyridine-5-carboxylic acids and esters
US3804843A (en) *	1971-12-23	1974-04-16	Squibb & Sons Inc	Amino derivatives of pyrazolopyridine carbonitriles
DE3145287A1 (de)	1981-11-14	1983-05-19	Troponwerke GmbH & Co KG, 5000 Köln	Pyrrolo (2.3-d)pyrimidine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
IT1154024B (it) *	1982-09-22	1987-01-21	Lepetit Spa	Derivati pridinici e procedimento per la loro produzione
US4605642A (en)	1984-02-23	1986-08-12	The Salk Institute For Biological Studies	CRF antagonists
US5063245A (en)	1990-03-28	1991-11-05	Nova Pharmaceutical Corporation	Corticotropin-releasing factor antagonism compounds
JPH05196008A (ja)	1991-11-20	1993-08-06	Myotoku Kk	空気圧動作装置とその制御装置
IT222061Z2 (it)	1991-12-03	1994-12-29	Hydro Aluminium Systems Spa	Complesso di profilati metallici per serramenti muniti di squadrette di rinforzo
WO1993010715A2 (en)	1991-12-03	1993-06-10	Vesitec Medical, Inc.	Surgical treatment of stress urinary incontinence
JPH0669494B2 (ja)	1991-12-04	1994-09-07	南雄河野	医療用窓付断熱カテーテル
TW370529B (en) *	1992-12-17	1999-09-21	Pfizer	Pyrazolopyrimidines
DK0674641T3 (da) *	1992-12-17	1999-09-27	Pfizer	Pyrrolopyrimidiner som CRF-antagonister
JP3398152B2 (ja)	1993-10-12	2003-04-21	ブリストル‐マイヤーズ・スクイブ・ファーマ・カンパニー	１ｎ−アルキル−ｎ−アリールピリミジンアミンおよびその誘導体

1995
- 1995-05-18 WO PCT/IB1995/000373 patent/WO1995034563A1/en active IP Right Grant
- 1995-05-18 RU RU96123712/04A patent/RU2135498C1/ru not_active IP Right Cessation
- 1995-05-18 AT AT95917436T patent/ATE182332T1/de not_active IP Right Cessation
- 1995-05-18 EP EP95917436A patent/EP0765327B1/en not_active Expired - Lifetime
- 1995-05-18 AU AU23505/95A patent/AU687196B2/en not_active Ceased
- 1995-05-18 DE DE69510940T patent/DE69510940T2/de not_active Expired - Fee Related
- 1995-05-18 NZ NZ284846A patent/NZ284846A/xx unknown
- 1995-05-18 HU HU9603469A patent/HU219911B/hu not_active IP Right Cessation
- 1995-05-18 DK DK95917436T patent/DK0765327T3/da active
- 1995-05-18 JP JP8501868A patent/JP2891544B2/ja not_active Expired - Fee Related
- 1995-05-18 CN CN95193638A patent/CN1056611C/zh not_active Expired - Fee Related
- 1995-05-18 MX MX9606504A patent/MX9606504A/es not_active IP Right Cessation
- 1995-05-18 CA CA002192820A patent/CA2192820C/en not_active Expired - Fee Related
- 1995-05-18 PL PL95317705A patent/PL181895B1/pl not_active IP Right Cessation
- 1995-05-18 CZ CZ19963670A patent/CZ287613B6/cs not_active IP Right Cessation
- 1995-05-18 KR KR1019960707183A patent/KR100235277B1/ko not_active Expired - Fee Related
- 1995-05-18 ES ES95917436T patent/ES2135062T3/es not_active Expired - Lifetime
- 1995-05-25 TW TW084105306A patent/TW432064B/zh active
- 1995-06-05 IL IL11400395A patent/IL114003A/xx not_active IP Right Cessation
- 1995-06-07 BR BR9502707A patent/BR9502707A/pt not_active IP Right Cessation
- 1995-06-07 ZA ZA954679A patent/ZA954679B/xx unknown
- 1995-06-08 CO CO95024908A patent/CO4290424A1/es unknown
- 1995-06-08 PE PE1995270715A patent/PE13396A1/es not_active Application Discontinuation
1996
- 1996-12-13 FI FI965022A patent/FI112659B/fi active
- 1996-12-13 NO NO965378A patent/NO307968B1/no not_active IP Right Cessation
1999
- 1999-03-11 US US09/266,353 patent/US6248753B1/en not_active Expired - Fee Related
- 1999-09-08 GR GR990402259T patent/GR3031166T3/el unknown

Also Published As

Publication number	Publication date
PL181895B1 (pl)	2001-10-31
TW432064B (en)	2001-05-01
IL114003A (en)	1999-12-31
EP0765327B1 (en)	1999-07-21
ES2135062T3 (es)	1999-10-16
DK0765327T3 (da)	1999-11-29
DE69510940T2 (de)	1999-11-11
CA2192820A1 (en)	1995-12-21
US6248753B1 (en)	2001-06-19
NO965378L (no)	1996-12-13
KR100235277B1 (ko)	1999-12-15
CZ287613B6 (en)	2001-01-17
MX9606504A (es)	1997-03-29
CN1150803A (zh)	1997-05-28
PL317705A1 (en)	1997-04-28
EP0765327A1 (en)	1997-04-02
CZ367096A3 (en)	1997-10-15
FI965022L (fi)	1996-12-13
JP2891544B2 (ja)	1999-05-17
JPH09507855A (ja)	1997-08-12
CA2192820C (en)	2000-11-28
RU2135498C1 (ru)	1999-08-27
CN1056611C (zh)	2000-09-20
DE69510940D1 (de)	1999-08-26
NO307968B1 (no)	2000-06-26
ZA954679B (en)	1996-12-09
FI112659B (fi)	2003-12-31
NZ284846A (en)	1998-12-23
AU687196B2 (en)	1998-02-19
HU219911B (hu)	2001-09-28
GR3031166T3 (en)	1999-12-31
CO4290424A1 (es)	1996-04-17
NO965378D0 (no)	1996-12-13
HUT75776A (en)	1997-05-28
WO1995034563A1 (en)	1995-12-21
HU9603469D0 (en)	1997-02-28
BR9502707A (pt)	1996-06-04
AU2350595A (en)	1996-01-05
PE13396A1 (es)	1996-04-27
ATE182332T1 (de)	1999-08-15
IL114003A0 (en)	1995-10-31

Publication	Publication Date	Title
DK0765327T3 (da)	1999-11-29	Pyrazolo- og pyrrolopyridiner
FI935585A0 (fi)	1993-12-13	Pyrrolopyrimidiner
EE200000318A (et)	2001-08-15	Uudsed ühendid
PT966447E (pt)	2003-07-31	Moleculas pequenas uteis no tratamento de doencas inflamatorias
FI963070A0 (fi)	1996-08-02	Klooripyrimidiinivälituotteita
YU51095A (sh)	1998-07-10	Benzokazolil - i benzotiazolil-oksazo lidinoni
FI952721L (fi)	1995-12-04	Aine maksa-sappi-sairauksien hoitamiseksi
ES2192839T3 (es)	2003-10-16	Timosina beta 4 oxidada.
FI910903L (fi)	1991-08-27	Poroest keramiskt kropp.
DE3883966D1 (de)	1993-10-14	Behandlung durchlässiger membranen.
TR200103125T2 (tr)	2002-04-22	Otizmin iyileştirilmesinde kullanıma yönelik antikonvülsan türevleri.
ATE261434T1 (de)	2004-03-15	Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten
NO913117L (no)	1992-02-11	Fremgangsmaate for behandling av benoedeleggende sykdommer.
FI944563A0 (fi)	1994-09-30	Mikro-organismeja, valmistusmenetelmä ja käyttö
NO20005548D0 (no)	2000-11-03	Mykobakterieinhibitorer
DE69114853D1 (de)	1996-01-04	Abwasserbehandlung.
NO982151L (no)	1998-07-03	Hemoregulatoriske forbindelser
FI972637A0 (fi)	1997-06-19	K-ryhmän vitamiinin käyttö lisäkilpirauhasen liikatoiminnan hoitoon
TR199800705T2 (fi)	1998-09-21
YU40098A (sh)	1999-09-27	Upotreba olanzapina za dobijanje leka
FI921906A0 (fi)	1992-04-29	Faestanordning foer konstvagina.